The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
D050197:Atherosclerosis / Q000209:etiology* / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D008078:Cholesterol, LDL / Q000097:blood*; D050171:Dyslipidemias / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D007249:Inflammation / Q000209:etiology* / Q000517:prevention & control*; D024821:Metabolic Syndrome / Q000150:complications*; D012307:Risk Factors
D015415:Biomarkers; D008078:Cholesterol, LDL; D002097:C-Reactive Protein